Friday, November 22, 2024 11/22/2024

Identification of bacterial strains for development of an oral probiotic aimed at increasing nitric oxide bioavailability

Award Number: R21DE032197
ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

Nitric oxide (NO) plays critical roles in a myriad of cellular and molecular mechanisms regulating physiology and function of various organs and systems. Depletion of NO and its reduced bioavailability contributes to the pathology of several human diseases including anemia, malaria, heart failure, obesity, diabetes and neurodegeneration. Recent reports suggest that oral microbiota regulate NO homeostasis through the action of some bacteria that have the ability to perform reduction of the nutrient anion nitrate to nitrite and NO. Several clinical trials have taken advantage of this nitrate-nitrite-NO cycle employing oral nitrate to deliver NO. However, many individuals do not respond to oral nitrate, and we hypothesize that this is due to a deficiency in nitrate to nitrite converting bacteria. Hence, developing microbiome modulators like probiotics to enhance and/or perform increased nitrate reduction and NO formation can potentially serve as a solution to recover diminished NO levels and bioavailability. The goal of this project is to test the role of oral bacteria in determining the extent of conversion of oral nitrate to plasma nitrite while developing novel human-origin probiotics of nitrate-nitrite-NO formation abilities and determine their adherence potential to colonize and form biofilms in epithelia. In Aim 1 we will use novel, high throughput screening assays to identify candidate bacterial strains with efficient nitrate to nitrite conversion abilities obtained from the oral cavity and characterize these strains. In Aim 2 we will determine the oral cavity colonizing capabilities of the nitrate to nitrite converting bacterial strains. In Aim 3, we will test the role of these bacterial strains’ in determining the extent of conversion of oral nitrate to plasma nitrite in a murine model. Successful completion of these studies could lead to probiotics against human diseases caused by NO homeostasis abrogation.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $223,916 )
2024	2024	WAKE FOREST UNIVERSITY	1834 WAKE FOREST RD	WINSTON SALEM	NC	27109	FORSYTH	USA	Oral Diseases and Disorders Research	000	2	6/11/2024	NON-COMPETING CONTINUATION	$223,916
														Subtotal = $223,916

Issue Date FY: 2023 ( Subtotal = $197,783 )
2023	2023	WAKE FOREST UNIVERSITY	1834 WAKE FOREST RD	WINSTON SALEM	NC	27109	FORSYTH	USA	Oral Diseases and Disorders Research	000	1	5/23/2023	NEW	$209,158
2023	2023	WAKE FOREST UNIVERSITY	1834 WAKE FOREST RD	WINSTON SALEM	NC	27109	FORSYTH	USA	Oral Diseases and Disorders Research	001	1	5/31/2023	NEW	-$11,375
														Subtotal = $197,783

Grand Total All Awards = $421,699

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Identification of bacterial strains for development of an oral probiotic aimed at increasing nitric oxide bioavailability

Award Number: R21DE032197

ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer